DaVita Inc
NYSE:DVA

Watchlist Manager
DaVita Inc Logo
DaVita Inc
NYSE:DVA
Watchlist
Price: 113.94 USD -0.5% Market Closed
Market Cap: 8B USD

DaVita Inc
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

DaVita Inc
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
DaVita Inc
NYSE:DVA
Free Cash Flow
$1.3B
CAGR 3-Years
4%
CAGR 5-Years
-3%
CAGR 10-Years
13%
Quest Diagnostics Inc
NYSE:DGX
Free Cash Flow
$1.4B
CAGR 3-Years
-2%
CAGR 5-Years
0%
CAGR 10-Years
9%
CVS Health Corp
NYSE:CVS
Free Cash Flow
$6.3B
CAGR 3-Years
-31%
CAGR 5-Years
-13%
CAGR 10-Years
0%
Cigna Corp
NYSE:CI
Free Cash Flow
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Free Cash Flow
$1.4B
CAGR 3-Years
-2%
CAGR 5-Years
-2%
CAGR 10-Years
9%
Guardant Health Inc
NASDAQ:GH
Free Cash Flow
-$262.2m
CAGR 3-Years
12%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
No Stocks Found

DaVita Inc
Glance View

In the intricate network of healthcare services, DaVita Inc. stands as a pivotal player, focusing on the often-overlooked but critical field of kidney care. Rooted in its mission to improve patients' quality of life by innovating kidney care therapies, DaVita has cultivated a robust operation primarily revolving around dialysis services. Chronic Kidney Disease (CKD) and kidney failure are rising global health concerns, necessitating regular dialysis treatments for affected individuals. DaVita serves this need through a network of dialysis centers, offering both in-center and at-home dialysis options. By prioritizing patient comfort and convenience alongside medical efficiency, DaVita has positioned itself as a go-to choice for those requiring ongoing renal care, effectively making the process as seamless as possible for patients. The business model of DaVita hinges on its ability to deliver consistent, high-quality care while managing costs—a balance crucial to success in the healthcare industry. Revenue flows in from both governmental programs such as Medicare and private health insurers, which fund the dialysis treatments for insured patients. DaVita's strategic strength lies in its operational scale, with a vast number of outpatient dialysis centers across the U.S. and internationally. This extensive reach not only strengthens its market position but also provides a wealth of data and feedback, fueling further innovation and efficiency improvements. By leveraging this extensive network, DaVita continues to tap into the growing demand for accessible, comprehensive kidney care services, reinforcing its commitment to patient-centered healthcare delivery while sustaining its financial growth.

DVA Intrinsic Value
268.92 USD
Undervaluation 58%
Intrinsic Value
Price

See Also

What is DaVita Inc's Free Cash Flow?
Free Cash Flow
1.3B USD

Based on the financial report for Sep 30, 2025, DaVita Inc's Free Cash Flow amounts to 1.3B USD.

What is DaVita Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
13%

Over the last year, the Free Cash Flow growth was -9%. The average annual Free Cash Flow growth rates for DaVita Inc have been 4% over the past three years , -3% over the past five years , and 13% over the past ten years .

Back to Top